|
|
| Line 1: |
Line 1: |
| {| style="border: 0px; font-size: 90%; margin: 3px; width: 500px;" align=center
| | #REDIRECT[[HIV AIDS primary prevention#Immunization in HIV Patients]] |
| |valign=top|
| |
| |+
| |
| ! style="background: #4479BA; color:#FFF; width: 200px;" | Vaccine
| |
| ! style="background: #4479BA; color:#FFF; width: 150px;" | CD4 < 200 cells/µL
| |
| ! style="background: #4479BA; color:#FFF; width: 150px;" | CD4 ≥ 200 cells/µL
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Influenza
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center" colspan=2| 1 dose annually (Inactivated Influenza Vaccine)
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Tetanus, diphtheria, pertussis (Td/Tdap)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center" colspan=2| Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Varicella
| |
| | style="padding: 5px 5px; background: #F5F5F5; text-align:center; color:red"| Contraindicated
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;"| 2 doses
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Human papillomavirus (HPV)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center" colspan=2| 3 doses through age of 26 yrs
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Zoster
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;color:red"| Contraindicated
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;"| Not Recommended
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Measles, mumps, rubella (MMR)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;color:red"| Contraindicated
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;"|1 or 2 doses
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Pneumococcal 13-valent conjugate (PCV13)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" colspan=2 | 1 dose followed by a booster at 5 yrs
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Pneumococcal polysaccharide (PPSV23)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" | 1 dose
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;"| 1 dose
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Meningococcal
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" colspan=2 | Recommended if some other risk factor is present
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Hepatitis A
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" colspan=2 | Recommended if some other risk factor is present
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | Hepatitis B
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" | 3 doses
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;"| 3 doses
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |Haemophilus influenzae type b (Hib)
| |
| | style="padding: 5px 5px; background: #F5F5F5;text-align:center;" colspan=2 | Recommended if some other risk factor is present
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" colspan=3| <small>Table adapted from CDC <ref>{{cite web | title=CDC Recommended Adult Immunization Schedule—United States - 2014| url=http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-pocket-size.pdf }} </ref></small>
| |
| |}
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |